Fang yi qing feng shi granule

Fang yi qing feng shi granule is a Chinese patent medicine composed of eight traditional Chinese medicinal ingredients. It is produced using modern pharmaceutical technology and was approved by the China Food and Drug Administration (CFDA) in 2005. The primary indication for this product is the treatment of rheumatoid arthritis, including malignant rheumatoid arthritis. Clinical studies have evaluated its efficacy and safety in subjects with rheumatoid arthritis, using randomized, double-blind, placebo-controlled designs[1][2][3]. The precise mechanism of action has not been elucidated in Western pharmacological terms; as a multi-ingredient herbal formulation, it likely exerts immunomodulatory and anti-inflammatory effects through multiple pathways.

Brand names

Fangyi

Other names

Fang yi Qing Feng Shi Granules